Group 1: Vitamin B1 Overview - Vitamin B1 is primarily used in feed, food, and pharmaceutical industries. The main competitors are Hubei Huazhong and Jiangxi Tianxin. Current product prices have increased compared to the beginning of the year [1]. Group 2: Vitamin B3 Overview - The global market capacity for Vitamin B3 is relatively large. Since the beginning of the year, raw material prices have decreased, leading to a slight increase in product prices and an improvement in gross profit margins [2]. Group 3: Vitamin K3 and Chrome Tanning Agent Overview - The company is the largest producer of Vitamin K3 globally, with a production capacity of 3,000 tons. Since 2013, the gross profit margin for K3 has remained stable due to low raw material prices. The chrome tanning agent industry is currently undergoing a reshuffle due to high raw material prices and environmental pressures, impacting sales in the short term [2]. Group 4: Chrome Waste Sludge Utilization Project - The chrome waste sludge cleaning and comprehensive utilization project is currently in a pilot phase in Haining, collaborating with local tanning enterprises. Revenue sources include sludge treatment fees and reduced raw material costs. The focus for 2014 is on market promotion [2]. Group 5: Raw Material Market Situation - The price of the main raw material, sodium aluminate, experienced a slight increase in the first half of the year. In the second half, with the completion of technical upgrades by related production enterprises, the supply of sodium aluminate is expected to become more abundant [2].

附件二：投资者关系活动记录表格式 证券代码： 002562 证券简称：兄弟科技 兄弟科技股份有限公司投资者关系活动记录表 编号：2014-005 | --- | --- | --- | |------------|-------------------------|----------------------------------------------------------| | | | | | 投资者关系 | □ 特定对象调研 | □ 分析师会议 | | 活动类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | ■ 现场调研 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名 | 方正证券 吴钊华 | | | 称及人员姓 | 方正证券 程 磊 | | | 名 | 日信证券 付豪杰 | | | 时间 | 2014 年 6 月 27 | 日 | | 地点 | 证券部会议室 | | | 上市公司接 | 董事会秘书 钱柳华 | | | 待人员姓名 | 证券投资部 朱益飞 | | | 投资者关系 | | 调研公司发展和行业情况（以调研机构 ...

Group 1: Vitamin B1 Overview - Vitamin B1 is primarily used in feed, food, and pharmaceutical industries, with a global demand of approximately 7,500-8,000 tons [2] - The company is currently in a phase of halting external quotations for Vitamin B1 [2] Group 2: Vitamin K3 Overview - The company is the largest global producer of Vitamin K3, with a production capacity of 3,000 tons [3] - The production facility is equipped with the most advanced technology, maintaining top-tier product yield, quality, and waste discharge levels [3] - The combined gross profit margin for Vitamin K3 and chromium tanning agents has improved compared to the same period last year [3] Group 3: Vitamin B3 Overview - The global market capacity for Vitamin B3 is estimated at 50,000-60,000 tons, with the company ranking among the top four in market share [3] - Raw material prices for Vitamin B3 have decreased compared to last year, while product prices have seen a slight increase, leading to improved gross margins due to economies of scale [3] Group 4: Leather Chemicals Project Overview - The company's leather additives are non-standard products with a wide variety and significant market potential, providing stable profits [3] - The domestic market for mid-to-high-end leather additives is largely reliant on imports [3] Group 5: Jiangxi Industrial Park Future Planning - The first phase of the Jiangxi project is planned for 800 acres, focusing on projects related to the company's main business or with similar customer bases [3] - The company has sufficient project reserves, but specific details are not disclosed and will be announced in future communications [3]

附件二：投资者关系活动记录表格式 编号：2015-003 证券代码： 002562 证券简称：兄弟科技 兄弟科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |------------|-----------------------------|----------------------------------------------------------| | | | | | 投资者关系 | □ 特定对象调研 | □ 分析师会议 | | 活动类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | ■ 现场调研 | | | | □ 其他 | | | 参与单位名 | 西南证券股份有限公司 张汪强 | | | 称及人员姓 | | 上海荣正投资咨询有限公司 曾国鑫 鲁 红 | | 名 | | 北京宏道投资管理有限公司 季 巍 | | | | 浙江首发创业投资有限公司 丁谢峰 | | | 上海德汇集团有限公司 潘学诗 | | | | 个人投资者 孙荣昌 | | | 时间 | 2015 年 8 月 5 日 | | | 地点 | 证券投资部会议 ...

Group 1: Investor Relations Activities - The investor relations activity was categorized as "Other" (Investor Reception Day) [2] - Participants included representatives from Jiuren Capital and individual investors [2] - The meeting took place on April 16, 2015, at Haining Pidu Jinjiang Hotel [2] Group 2: Vitamin Market Insights - The global vitamin market is experiencing stable demand with an annual growth rate of approximately 3%-5% [3] - The price of Vitamin K3 was increased by about 35% in the first quarter due to rising raw material costs [3] - The total global demand for Vitamin B5 in 2013 was approximately 21,000 tons, with significant growth expected in developing countries [3] Group 3: Project Development Updates - The company has acquired 700 acres of industrial land, with construction for the Vitamin B3 and B5 projects set to begin in the second quarter of 2015 [3] - The first phase of the project is expected to complete construction and enter trial production by the third quarter of 2016 [3] Group 4: Leather Chemicals Market - The leather industry has faced challenges due to high raw material prices and environmental pressures, impacting sales of leather chemicals [4] - The company has established a professional application research team to provide solutions aimed at reducing costs and improving product quality [4] - Marketing networks have been successfully established in South America, North Africa, and Southeast Asia, yielding positive sales results [4] Group 5: Future Development Directions - The company plans to focus on its core business while pursuing both organic growth and mergers/acquisitions [4] - There will be increased investment in high-value-added leather auxiliary products and further development of feed additives, food additives, and pharmaceutical raw materials [4] Group 6: Arbitration Situation - The company has executed part of the equity transfer prepayment, with ongoing execution of subsequent payments [4] - Although the execution speed is slow, the current situation indicates a high level of assurance for execution [4]

附件二：投资者关系活动 证券代码：002562 证券简称：兄弟科技 兄弟科技股份有限公司投资者关系活动记录表 编号：2015-005 | --- | --- | --- | |----------------|-------------------------------|--------------------------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | ■ 现场参观 | | | | □ 其他 | | | 参与单位名称及 | 国泰基金 叶 烽 | | | 人员姓名 | 国海证券 司马湫 | | | | 洛卡商务咨询 苗 壮 | | | 时间 | 证券投资部会议室 | | | 地点 | 2015 年 11 月 6 日 | | | 上市公司接待人 | 董事会秘书 钱柳华 | | | 员姓名 | 董事会秘书助理 沈 洁 | | | 投资者关系活动 | | 调研公司发展和行业情况（以调研机 ...

Group 1: Investor Relations Activities - The investor relations activity included a site visit with participation from various financial institutions such as Guosen Securities and Tianhong Asset Management [2] - The meeting took place in October 2015 at the company's securities investment department meeting room [2] Group 2: Vitamin Market Situation - The company has achieved full capacity operation for its "annual production of 5,000 tons of Vitamin B3" project [3] - The "annual production of 13,000 tons of Vitamin B3 and 20,000 tons of 3-cyanopyridine construction project" aims to address production scale limitations and enhance market competitiveness [3] - The sales promotion of pharmaceutical-grade Vitamin B1 is progressing smoothly, with a stable competitive landscape in the market [3] Group 3: Leather Chemicals Market Situation - The leather industry in China has been undergoing environmental upgrades and industry consolidation, with signs of industrial transfer in the upstream processes [3] - The company has launched higher value-added coating agent products in the leather additives sector, which is expected to improve overall profitability [3] - The qualification certificate for the chromium-containing waste comprehensive utilization project was obtained in the first half of the year, and market promotion efforts are actively underway [3] Group 4: Project Construction Progress - The company officially started the construction of projects in the second quarter of the year, including Vitamin B3, Vitamin B5, and cogeneration projects [3] - The cogeneration project is expected to complete construction and begin trial production in the third quarter of 2016, providing centralized heating for the Qishan Industrial Park [3] Group 5: Legal Matters - The company is actively advancing the arbitration situation with Zhonghua Chemical and has executed part of the equity transfer prepayment at the beginning of the year [4]

Group 1: Market Overview - The global vitamin market is experiencing stable demand with an annual growth rate of approximately 3% to 5% [2] - Vitamins are widely used in various fields, including feed additives, food additives, pharmaceutical raw materials, and cosmetics [2] Group 2: Company Performance - In the first half of the year, the price of Vitamin B3 increased by about 20%, and the company expects its "annual production of 5,000 tons of Vitamin B3 project" to operate at full capacity this year [2] - The non-public offering fundraising project for "annual production of 13,000 tons of Vitamin B3 and 20,000 tons of cyano-pyridine" will effectively address limitations such as small production scale and incomplete industrial chain, thereby reducing costs and enhancing customer satisfaction [2] - The company has a production capacity of 3,000 tons/year for Vitamin K3, with a price increase of approximately 35% in the first quarter [2] - The recent price increase for Vitamin B1 products is about 10%, with a stable competitive landscape [2] Group 3: Project Development - The choice of Jiangxi for project location is due to its status as a national-level chemical park with excellent deep-water coastline and convenient transportation [2] - The company has officially launched project construction in the second quarter of this year, with the first phase including Vitamin B3, Vitamin B5, and cogeneration projects, expected to complete construction and enter trial production by the first quarter of 2016 [2]

附件二：投资者关系活动 证券代码：002562 证券简称：兄弟科技 兄弟科技股份有限公司投资者关系活动记录表 编号：2016-001 | --- | --- | --- | |---------------------|---------------------------------|--------------------------------------------------------------| | | | | | 投资者关系活动 类别 | □ 特定对象调研 □ 媒体采访 | □ 分析师会议 □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | ■ 现场参观 | | | | □ 其他 | | | 参与单位名称及 | 兴业全球 张 弘 | | | 人员姓名 | 景顺长城 张伟保 民生证券 沈晓源 | | | | 长信基金 张家浩 | | | 时间 | 证券投资部会议室 | | | 地点 | 2016 年 1 月 14 日 | | | 上市公司接待人 | 董事长 钱志达 | | | 员姓名 | 董事会秘书 钱柳华 | | | | 董事会秘书助理 沈 洁 | | | 投资者关系活 ...